Literature DB >> 32713676

Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis.

Julie C Worrell1, Steven O'Reilly2.   

Abstract

Systemic Sclerosis (SSc) is an autoimmune idiopathic connective tissue disease, characterized by aberrant fibro-proliferative and inflammatory responses, causing fibrosis of multiple organs. In recent years the interactions between innate and adaptive immune cells with resident fibroblasts have been uncovered. Cross-talk between immune and stromal cells mediates activation of stromal cells to myofibroblasts; key cells in the pathophysiology of fibrosis. These cells and their cytokines appear to mediate their effects in both a paracrine and autocrine fashion. This review examines the role of innate and adaptive immune cells in SSc, focusing on recent advances that have illuminated our understanding of ongoing bi-directional communication between immune and stromal cells. Finally, we appraise current and future therapies and how these may be useful in a disease that currently has no specific disease modifying treatment.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Adaptive immunity; B cell; CD4+T cell; Cross-talk; Cytokine; Fibroblast; Fibrosis; Systemic sclerosis

Year:  2020        PMID: 32713676     DOI: 10.1016/j.jaut.2020.102526

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

Review 1.  B cells in systemic sclerosis: from pathophysiology to treatment.

Authors:  Konstantinos Melissaropoulos; Dimitrios Daoussis
Journal:  Clin Rheumatol       Date:  2021-03-21       Impact factor: 2.980

Review 2.  The Yin and Yang of IL-17 in Systemic Sclerosis.

Authors:  Lanxuan Wei; David Abraham; Voon Ong
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 3.  The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications.

Authors:  Mohsen Rokni; Mina Sadeghi Shaker; Hoda Kavosi; Shahrzad Shokoofi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Arthritis Res Ther       Date:  2022-05-13       Impact factor: 5.606

Review 4.  Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.

Authors:  Ming Zhao; Jiali Wu; Haijing Wu; Amr H Sawalha; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-15       Impact factor: 8.667

5.  Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction.

Authors:  Julien Guiot; Makon-Sébastien Njock; Béatrice André; Fanny Gester; Monique Henket; Dominique de Seny; Catherine Moermans; Michel G Malaise; Renaud Louis
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

Review 6.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

7.  Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching.

Authors:  Xiaoyang Yue; Junping Yin; Xiaoqing Wang; Harald Heidecke; Alexander Maximilian Hackel; Xiaoru Dong; Brigitte Kasper; Lifang Wen; Liang Zhang; Kai Schulze-Forster; Juliane Junker; Hanna Grasshoff; Antje Müller; Gerd Wallukat; Ingolf Schimke; Julian Zeiner; Lisa Marie Deckstein; Nicole Mertens; Anja Kerstein-Staehle; Jennifer Elisabeth Hundt; Evi Kostenis; Xinhua Yu; Gabriela Riemekasten; Frank Petersen
Journal:  Ann Rheum Dis       Date:  2022-05-20       Impact factor: 27.973

Review 8.  Role of NLRP3 inflammasome in systemic sclerosis.

Authors:  Cong Lin; Zhixing Jiang; Ling Cao; Hejian Zou; Xiaoxia Zhu
Journal:  Arthritis Res Ther       Date:  2022-08-16       Impact factor: 5.606

9.  Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.

Authors:  J Lapoirie; L Tran; L Piazza; C Contin-Bordes; M E Truchetet; F Bonnet
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

10.  IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts.

Authors:  Eleonora Adami; Sivakumar Viswanathan; Anissa A Widjaja; Benjamin Ng; Sonia Chothani; Nevin Zhihao; Jessie Tan; Pei Min Lio; Benjamin L George; Umut Altunoglu; Kakaly Ghosh; Bhairav S Paleja; Sebastian Schafer; Bruno Reversade; Salvatore Albani; Andrea Low Hsiu Ling; Steven O'Reilly; Stuart A Cook
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.